Gayane Sargis Vardanyan

Gayane Sargis Vardanyan

Auto-generated profile, based on publicly available information

Gayane Sargis Vardanyan

Department of Biochemistry, Yerevan State Medical University, Yerevan, Armenia

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 October 2020 in Future Medicinal Chemistry
Verified
Journal Article
Closed access
GVGayane Sargis Vardanyan
Gayane Sargis Vardanyan
HHHasmik Harutyunyan
Hasmik Harutyunyan
MAMichail Iosif Aghajanov
Michail Iosif Aghajanov
RVRuben Sargis Vardanyan
Ruben Sargis Vardanyan
In recent decades, obesity has become a pandemic disease and appears to be an ultimate medical and social problem. Existing antiobesity drugs show low efficiency and a wide variety of side effects....

20 March 2009 in Neurochemical Journal
Verified
Journal Article
Closed access
PDF file
GVG. S. Vardanyan
G. S. Vardanyan
AAA. R. Alaverdyan
A. R. Alaverdyan
Protein kinase C (PKC) is actually a family of enzymes that play an important role in intracellular signal transduction by protein phosphorylation. During the last twenty years, the data on the roles of this family in cell physiology and pathology were substantially broadened. In this article, we review the results of many studies concerning the structural specificity of PKC and regulation of its activity. Special attention is paid to the possible role of PKC in the progress of diabetic neuropathy. Future directions are suggested concerning the use of PKC inhibitors for the correction of neuropathic disturbances during diabetes.

1 March 2023 in Neurochemical Journal
Verified
Journal Article
Closed access
PDF file
HHHasmik Harutyunyan
Hasmik Harutyunyan
MAM. I. Aghajanov
M. I. Aghajanov
GVG. S. Vardanyan
G. S. Vardanyan
Pain is one of the most frequent symptoms accompanying diseases. Every type of pain invokes various molecular mechanisms leading to the central effects, and hence the pain response. The plasticity of the nervous system is a unique property enabling it to change the number and quality of neural connections in order to adapt to the environment. This property is the basis of memory, particularly “pain memory”. The formalin test is widely used as an experimental model of biphasic pain in laboratory animals. We supposed that adding the second injection of a noxious agent to the classical test will enhance the pain response and let us observe plastic changes in the central nervous system and in the periphery. The contralateral repetitive injection of formalin and capsaicin to the rat hind paw revealed an increase in pain score in Phase 1 and a decrease in Phase 2. In Freund’s adjuvant injected group the pain score in both phases was increased. Different patterns of spinal cord neuronal activity were observed in formalin, capsaicin, and Freund’s adjuvant injections. Contralateral repetitive administration of formalin and capsaicin, but not Freund’s adjuvant revealed a “pain memory”, a pain response in previously injected but unaffected in the second injection paw. Analysis of the “pain memory” based on our previous studies revealed its overall central character and lack of association with inflammation. Investigations of mechanisms underlying each type of pain and deep analysis of pain memory may open new perspectives to prevent and treat pain.